Deka Bank Deutsche Girozentrale Spectrum Pharmaceuticals Inc Transaction History

Deka Bank Deutsche Girozentrale

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$1.27 - $2.42 $54,356 - $103,576	-42,800 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$2.99 - $4.9 $127,972 - $209,720	42,800 New	42,800 $181,000
Q4 2019 Feb 04, 2020	SELL	$3.5 - $10.35 $235,900 - $697,590	-67,400 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$7.03 - $9.7 $473,822 - $653,780	-67,400 Reduced 50.0%	67,400 $597,000
Q2 2019 Aug 01, 2019	BUY	$7.36 - $11.26 $924,416 - $1.41 Million	125,600 Added 1365.22%	134,800 $1.17 Million
Q1 2019 May 10, 2019	SELL	$9.08 - $11.84 $528,456 - $689,088	-58,200 Reduced 86.35%	9,200 $208,000
Q4 2018 Feb 12, 2019	BUY	$6.39 - $16.99 $371,898 - $988,817	58,200 Added 632.61%	67,400 $598,000
Q3 2018 Nov 09, 2018	SELL	$16.52 - $24.82 $994,504 - $1.49 Million	-60,200 Reduced 86.74%	9,200 $0
Q1 2018 May 03, 2018	BUY	$16.09 - $23.07 $1.12 Million - $1.6 Million	69,400 New	69,400 $1.14 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.